HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Oncologists play key role in diagnosing immune checkpoint inhibitor-induced myocarditis Drew Amorosi
-
- Cross-border partnership takes on ‘huge survival gap’ among children with leukemia Drew Amorosi
- Healio | HemOncToday announce 2023 Disruptive Innovators at ASCO Katrina Altersitz
- Healio’s Disruptive Innovators celebrate at ASCO Katrina Altersitz; Mark Leiser
- Mirvetuximab soravtansine data ‘practice changing’ for subset of women with ovarian cancer Devin McLaughlin
- One-third of women oncologists experience infertility Jennifer R. Southall
- Osimertinib after surgery reduces risk for death by 51% in resected EGFR-mutant NSCLC Matthew Shinkle
- Some patients with locally advanced rectal cancer can be spared pelvic radiation Devin McLaughlin
- Ribociclib regimen reduces recurrence risk in common breast cancer subtype Jennifer R. Southall
-
- Surgeon general: Burnout has many health care workers ‘in crisis’ Mark Leiser
- Tumor mutational burden associated with survival on immunotherapy across cancer types Jennifer R. Southall
- ‘Unacceptable situation’ in cancer care: Chemotherapy shortages impact majority of centers
- Vorasidenib first ‘game changer’ in 20 years for patients with IDH-mutant grade 2 glioma Matthew Shinkle
- Durvalumab regimens extend PFS in advanced endometrial cancer
- First-line combination extends PFS in lung cancer subgroup